Lv33
380 积分 2023-02-07 加入
Targeting the incretin system in obesity and type 2 diabetes mellitus
12天前
已完结
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
12天前
已完结
Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges
12天前
已完结
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
12天前
已完结
A New Protractor Potentiates Glucagon-Like Peptide 1 with Slow-Release Depot and Long-Term Action
22天前
已完结
Reconstituting the immune killing functions and improving the pharmacokinetics of nanobodies by rhamnolipid conjugation
26天前
已完结
Chemically engineered antibodies for autophagy-based receptor degradation
28天前
已完结
Blocking of FGFR4 signaling by F30 inhibits hepatocellular carcinoma cell proliferation through HMOX1-dependent ferroptosis pathway
1个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
2个月前
已完结
Refining the treatment of NSCLC according to histological and molecular subtypes
2个月前
已完结
皖公网安备34019202002308
